智通财经APP获悉，7月11日，中国证监会发布《境外发行上市备案补充材料要求(2025年7月4日—2025 年7月10日)》，证监会国际司共对7家企业出具补充材料要求。在公示中，证监会要求南京普爱医疗补 充说明公司及下属公司经营范围是否涉及《外商投资准入特别管理措施（负面清单）（2024年版）》领 域、本次拟参与"全流通"的股东所持股份是否存在被质押、冻结或其他权利瑕疵的情形等事项。据港交 所4月30日披露，南京普爱医疗递表港交所，国泰君安国际为其独家保荐人。 中国证监会请公司补充说明以下事项，并请律师核查并出具明确的法律意见： 一、请补充说明公司及下属公司经营范围是否涉及《外商投资准入特别管理措施（负面清单）（2024年 版）》领域。 三、请公司补充说明前期A股上市辅导备案及向深交所提交创业板上市申请的具体情况及终止原因，是 否计划继续推进A股上市及具体安排，是否存在对本次发行上市产生重大影响的情形。 招股书显示，普爱医疗专注于X射线成像技术，从最初的一款产品起步，截至最后实际可行日期(2025 年4月20日)，产品组合已扩展至逾100款型号，并以X射线管组件、高压发生器及三维成像技术等专有 技术为支撑。公 ...

压力太大，氢会"方"吗 半月谈记者 张漫子 "压力太大，我方了"——人真的能变"方"吗？当然不至于。这句"网言网语"，形容的是网友在压力之下 心情变化大，与日常判若两人。有谁愿意想一想，自然界中的元素，如果施以超强的高压，会发生怎样 根本性的变化？ 科学家就很想拿氢来试一试。这种宇宙中最轻、最简单也最古老、最丰富的元素，在元素周期表上有个 略"尴尬"的位置——身在第一主族的它，身边的锂、钠、钾之类都是所谓碱金属，唯有它是非金属！氢 就永远不可能成为金属吗？ 90年前，著名物理学家维格纳曾预言，极高压下，固态氢可以呈现出金属的性质。后来有人算了一下， 让氢金属化的压力得有500GPa（1GPa等于1万个大气压）——相当于一架停在针尖上的大型喷气式飞机 对针尖施加的力。 高压之下，氢到底会不会"方"，彻底变成金属？最近，中国科学家发现了一点线索。 探测氢在高压下的结构转变，首先得有真正称得上"高压"的环境。科学家为此发明了一个"法宝"——金 刚石对顶砧。 氢"变形记" 5月14日，《自然》发表了一项北京高压科学研究中心毛河光院士团队的重大成果：凭借一种极特殊 的"显微镜"——X射线纳米探针，他们窥见了高压（212 ...

导读： 近日，农业农村部发布多批政府采购意向，仪器信息网特对其中的仪器及监测服务品目进行梳理，统计出13项仪器及监测服务 采购意向，预算总额达1.46亿元。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日， 农业农村部发布 13 项仪器及监测服务采购意向，预算总额达 1.46 亿 元，涉及 稳定同位素质谱仪、激光共 聚焦显微拉曼光谱仪、X射线荧光分析仪 、农田氮磷流失与农业废弃物监测评价 等，预计采购时间为202 5 年 3~7 月。 农业农村部 202 5 年 3~7 月仪器设备采购 意向汇总表 4 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号立 场 | | | 预算 | 采 购 | | --- | --- | --- | --- | | 采购项目 | 需求概况 | | | | | | 万元 | 时 | | | | | 间 | | 环境保护科 | | | 202 | | 研监测所公 | 拟采购稳定同位素质谱仪、激光共聚焦显微拉曼 ...

2025 年 07 月 08 日 开源晨会 0708 ——晨会纪要 沪深300 及创业板指数近1年走势 数据来源：聚源 -16% 0% 16% 32% 48% 64% 2024-07 2024-11 2025-03 沪深300 创业板指 昨日涨跌幅前五行业 | 行业名称 | 涨跌幅(%) | | --- | --- | | 综合 | 2.572 | | 公用事业 | 1.867 | | 房地产 | 1.678 | | 轻工制造 | 1.523 | | 环保 | 1.101 | | 数据来源：聚源 | | 昨日涨跌幅后五行业 | 行业名称 | 涨跌幅(%) | | --- | --- | | 煤炭 | -2.04 | | 医药生物 | -0.969 | | 通信 | -0.775 | | 家用电器 | -0.696 | | 电子 | -0.665 | | 数据来源：聚源 | | 吴梦迪（分析师） wumengdi@kysec.cn 证书编号：S0790521070001 观点精粹 总量视角 （1）MEMS 惯导：随着下游低空经济、自动驾驶、机器人等应用领域起量，高 性能 MEMS 市场持续高景气。芯动联科作为国 ...

Core Viewpoint - The company, United Imaging Healthcare, has shown a significant increase in stock price and market capitalization, but its price-to-earnings (PE) ratio remains high compared to industry averages, indicating potential overvaluation [1][2]. Company Summary - United Imaging Healthcare's stock closed at 129.71 yuan, up 2.60%, with a rolling PE ratio of 84.26, marking a new low in 18 days and a total market capitalization of 106.90 billion yuan [1]. - The company operates in the medical device sector, providing high-performance medical imaging equipment, radiation therapy products, life science instruments, and digital healthcare solutions [1]. - As of the first quarter of 2025, the company had 117 institutional investors holding a total of 33,436.65 million shares, with a market value of 40.79 billion yuan [1]. Financial Performance - In the first quarter of 2025, the company reported revenue of 2.478 billion yuan, a year-on-year increase of 5.42%, and a net profit of 370 million yuan, up 1.87%, with a gross profit margin of 49.94% [2]. - The company's PE ratio is significantly higher than the industry average of 51.42 and the median of 37.44, indicating a potential premium valuation [2].

从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均51.42倍，行业中值37.44倍，超研股份排 名第96位。 股东方面，截至2025年3月31日，超研股份股东户数26755户，较上次减少23411户，户均持股市值35.28 万元，户均持股数量2.76万股。 7月7日，超研股份今日收盘26.63元，上涨2.86%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到72.07倍，创63天以来新低，总市值114.06亿元。 最新一期业绩显示，2025年一季报，公司实现营业收入9843.24万元，同比28.69%；净利润3932.20万 元，同比47.70%，销售毛利率73.83%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13超研股份72.0778.358.82114.06亿行业平均 51.4249.164.50106.60亿行业中值37.4437.842.5151.15亿1九安医疗10.2110.330.80172.35亿2英科医疗 10.4111.230.93164.55亿3新华医疗14.3013.251.1791.67亿4奥美医疗15.3415.031.5855.41亿5振德医疗 ...

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 X射线衍射（XRD）技术是物质结构分析的基石，在材料科学、化学、物理、地学及工程领域发挥着不可替代的作用。随着原位XRD、高分辨 显微衍射、AI辅助数据分析等前沿技术的突破，XRD正以前所未有的精度和效率推动着相关领域的持续发展。 2025年7月8日 ，仪器信息网将组织举办 第六届X射线衍射技术及应用进展网络研讨会 ，汇聚业内知名专家学者、企业代表， 共同探讨最新 XRD技术进展，解析复杂数据，优化仪器操作；深度聚焦XRD在新能源、半导体、制药等热点领域的落地案例，助力产学研用协同创新。 会议时间： 202 5年7月08 合作单位： 仪器信息网 会议日程： | 0 | 09:00 -- 09:30 | X射线衍射在二次电池研究中的应用 | 张吉东 | 中国科学院长春应用化学研究所 研究员 | | --- | --- | --- | --- | --- | | O | 09:30 -- 10:00 | 安东帕自动化多功能衍射仪XRDynamic 500在 | 郭健宁 | 安东帕(上海) 商贸有限 ...

Core Viewpoint - ShanghaiTech University has announced procurement intentions for 40 items of scientific instruments, with a total budget of 135 million yuan, scheduled for procurement between June and December 2025 [1][2]. Group 1: Procurement Overview - The total budget for the procurement of scientific instruments is 135 million yuan [1]. - The procurement includes various high-tech instruments such as high-performance oscilloscopes, scintillation detectors, and high-precision high-voltage power supplies [1][3]. Group 2: Specific Instruments and Budgets - High-performance oscilloscope: Budget of 200,000 yuan, procurement expected in August 2025 [3]. - Scintillation detector: Budget of 120,000 yuan, procurement expected in December 2025 [3]. - Air purification equipment: Budget of 105,000 yuan, procurement expected in August 2025 [3]. - High-precision high-voltage power supply: Budget of 160,000 yuan, procurement expected in September 2025 [4]. Group 3: Technical Specifications - The high-performance oscilloscope will have a bandwidth of 350 MHz to 6 GHz and a sampling rate of 16 GSa/s [3]. - The air purification equipment will maintain a cleanroom environment with ISO6 cleanliness level and temperature control precision of ±1℃ [3]. - The scintillation detector will be used for debugging and maintaining semiconductor detection systems [4]. Group 4: Future Implications - The procurement is aimed at enhancing research capabilities in various scientific fields, including quantum materials and advanced semiconductor technologies [1][6]. - The investment in high-tech instruments reflects the university's commitment to advancing its research infrastructure and supporting cutting-edge scientific exploration [1][7].

Core Viewpoint - Chao Yan Co., Ltd. has a closing price of 24.78 yuan, down 1.82%, with a rolling PE ratio of 67.06 times and a total market value of 10.614 billion yuan, indicating a higher valuation compared to the industry average [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, positioning Chao Yan Co., Ltd. at the 96th rank within the industry [1][2] - The industry average market value is 10.675 billion yuan, while the median market value is 5.063 billion yuan [2]

Company Overview - Shanghai United Imaging Healthcare Co., Ltd. specializes in providing high-performance medical imaging equipment, radiation therapy products, life science instruments, and digital healthcare solutions globally [1] - The main products include MRI systems, CT systems, XR systems, molecular imaging systems, medical linear accelerators, animal MRI, animal PET/CT, United Imaging Cloud platform, cloud film, cloud PACS, and digital healthcare solutions [1] Financial Performance - For Q1 2025, the company reported revenue of 2.478 billion yuan, a year-on-year increase of 5.42% [2] - The net profit for the same period was 370 million yuan, reflecting a year-on-year growth of 1.87% [2] - The gross profit margin stood at 49.94% [2] Market Position - As of July 2, the company's stock closed at 126.15 yuan, down 1.48%, with a rolling PE ratio of 81.95 times [1] - The total market capitalization reached 103.968 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, placing the company at the 102nd position in the industry ranking [1] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 21,435, up by 3,165 from the previous count [1] - The average market value of shares held per shareholder is 352,800 yuan, with an average holding of 27,600 shares [1] Intellectual Property - The company has applied for a total of 11,502 intellectual property rights, of which 5,882 have been granted [1] - During the reporting period, the company filed 1,079 new intellectual property applications and received 707 grants, including 766 invention patent applications and 465 granted invention patents [1]